|
ETV6 expression based on
|
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.702600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.094000E-01 |
| Normal-vs-Stage2 |
6.068800E-01 |
| Normal-vs-Stage3 |
5.569600E-01 |
| Normal-vs-Stage4 |
4.688000E-01 |
| Stage1-vs-Stage2 |
3.214600E-01 |
| Stage1-vs-Stage3 |
6.990200E-01 |
| Stage1-vs-Stage4 |
5.813600E-01 |
| Stage2-vs-Stage3 |
2.750400E-01 |
| Stage2-vs-Stage4 |
2.542800E-01 |
| Stage3-vs-Stage4 |
8.275400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.943400E-01 |
| Normal-vs-AfricanAmerican |
3.162400E-01 |
| Normal-vs-Asian |
7.625200E-01 |
| Caucasian-vs-AfricanAmerican |
6.493400E-01 |
| Caucasian-vs-Asian |
1.728420E-01 |
| AfricanAmerican-vs-Asian |
1.997190E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.262600E-01 |
| Normal-vs-Female |
7.523000E-01 |
| Male-vs-Female |
5.861000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.880600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.734600E-01 |
| Normal-vs-Age(61-80Yrs) |
5.231800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.017400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.917800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.862780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.469600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.324180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.181400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.208980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.488400E-01 |
| Classical-VS-Follicular |
3.99229982406268E-10 |
| Classical-VS-Other |
1.225780E-01 |
| Classical-VS-Normal |
1.019210E-01 |
| Tall-VS-Follicular |
8.982500E-04 |
| Tall-VS-Other |
2.001400E-01 |
| Tall-VS-Normal |
3.963800E-01 |
| Follicular-VS-Other |
6.752600E-01 |
| Follicular-VS-Normal |
4.364000E-03 |
| Other-VS-Normal |
3.681600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.087200E-01 |
| Normal-vs-N1 |
8.441400E-01 |
| N0-vs-N1 |
4.596400E-01 |
|
|
